Auntea Jenny Announces 2026 Interim Results
Xunce 2026 Interim Results: Revenue Up 389%, Net profit of nearly 100 million yuan, Token Revenue Emerges as a New Growth Engine
Aitenders Technologies Inc. (Formerly, eXeBlock Technology Corporation) Announces Closing of Reverse Takeover with Aitenders and Receipt of Conditional Listing Approval from the Canadian Securities Exchange
New Manitoba Bonus Prize Clue Released for The Great Canadian Treasure Hunt
GetHookd Releases API & MCP Server for AI-Powered Ecommerce Ad Research
Duet releases video depicting mechanism of action for its proprietary CpG-STAT3 inhibitors to coincide with…
New York, NY, and Tel Aviv, ISRAEL, Sept. 28, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos…
Three Biological-Based Herbicides Enter Late-Stage Development Phases; Potential $27 Billion Market DAVIS, Calif., Sept. 28,…
– Phase 2b study will investigate the efficacy of REVTx-99 on viral load and patient-reported…
NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an…
Christine Brown, Ph.D., of City of Hope will present at the First Annual Conference on…
Trudhesa is the First and Only Therapeutic to Use POD® Technology to Deliver Dihydroergotamine Mesylate…
NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Tryp Therapeutics Inc. (CSE:…
IRVINE, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical…
Full year data reinforce strong safety profile consistent with previous trials of ONS-5010 and with…
Study to focus on women of African American descent for expanded polygenic risk test MELBOURNE,…
– Small Business Innovation Research (SBIR) contract to support development of pipeline program SENTI-202, a…
Partnership to focus on empowering women to take ownership of their health and healthcare options…
Unique FAP targeting warhead combined with Actinium-225 or Lutetium-177 demonstrated complete tumor regression and long-term…
ZUG, Switzerland and CAMBRIDGE, Mass., Sept. 28, 2021 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP),…
Conference Call and Webcast Scheduled for October 12, 2021, 8:30 am ET NEW YORK, NY,…
DUBLIN, Ireland and CHICAGO, Sept. 28, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM)…
— ENA Respiratory engages PPD, Inc. for Phase 2 COVID-19 post-exposure prophylaxis study and hVIVO…
FORT LAUDERDALE, Fla., Sept. 28, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc. (NASDAQ: MOTS)…
Research demonstrates that platform technologies generate therapeutic molecules for selective delivery of immune activating signals,…